Silencing efficacy prediction: a retrospective study on target mRNA features.
about
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment.NLRP7 contributes to in vitro decidualization of endometrial stromal cells.Exploring PAZ/3'-overhang interaction to improve siRNA specificity. A combined experimental and modeling study.
P2860
Silencing efficacy prediction: a retrospective study on target mRNA features.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Silencing efficacy prediction: a retrospective study on target mRNA features.
@en
type
label
Silencing efficacy prediction: a retrospective study on target mRNA features.
@en
prefLabel
Silencing efficacy prediction: a retrospective study on target mRNA features.
@en
P2860
P356
P1433
P1476
Silencing efficacy prediction: a retrospective study on target mRNA features
@en
P2093
Devis Pascut
P2860
P356
10.1042/BSR20140147
P577
2015-03-31T00:00:00Z